Wednesday, 1st February 2023
<To guardian.ng
Search

BioNTech wants to ‘eradicate’ malaria with mRNA vaccine

After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.

Related

10 Jun 2021
President Joe Biden is expected to make the announcement before the G7 summit kicks off. The donation comes as the US attempts to reclaim its role as a global leader after four years of isolationism.
25 Jun 2021
The US Centers for Disease Control and prevention have confirmed that myocarditis and pericarditis can occur after mRNA vaccination in young people. But the cases are rare. Medical experts still recommend the shots.
1 Jul 2021
China has become the 40th country to be declared malaria-free. An expert team traveled in May this year to verify China's malaria-free status. It has not had an indigenous case for four years.
13 Jul 2021
BioNTech and Pfizer said an extra dose of their jab could boost immunity against the coronavirus delta variant. South Korea raised pandemic restrictions as cases hit the "maximum crisis level." Follow DW for the latest.
23 Jul 2021
The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.
27 Jul 2021
After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.
13 Sep 2021
BioNTech wants to continue the success of its COVID-19 vaccine and use mRNA technology to develop shots against malaria. But is production in Africa realistic?
20 Sep 2021
The announcement comes as coronavirus cases among children surge in the United States and other parts of the world.
2 Oct 2021
The FDA's limited approval comes weeks after US President Joe Biden's administration announced a sweeping plan that would allow nearly all American adults to get a third shot.
2 Oct 2021
The BioNTech/Pfizer vaccine for 5 to 11 year olds could be approved in the US as early as October. Meanwhile, Australia plans to stop paying workers affected by lockdowns. Follow DW for the latest.
6 Oct 2021
While the European Medicines Agency approved a third dose for people over 18-years-old, the agency said it was up to member states to decide whether to use them.
7 Oct 2021
The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine, the first against the mosquito-borne disease that kills more than 400,000 people a year, mostly African children.